Rapid Therapeutic Science Laboratories IncOOTC RTSL Stock Report

Rapid Therapeutic Science Laboratories, Inc. is a biotech company focused on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The Company is engaged in aerosol delivery of non-tetrahydrocannabinol (THC) cannabinoids to the systemic blood stream though the pulmonary route of administration. The Company is developing and manufacturing aerosol delivery devices for existing active ingredients. The Company offers metered dose inhaler (MDI) devices that deliver a measured amount of aerosolized inhalant in a mist to the lungs. The Company also offers a sublingual oral spray device and water-soluble cannabidiol (CBD) and cannabigerol (CBG) isolates. The Company’s nhaler MDI provides 100 metered doses; five milligrams (mg) of its proprietary active pharmaceutical ingredient (API) pure cannabinoid isolate blend of NPC known as N-PsicanTM; 500 (mg) of API per MDI, and Zero THC.